METHOD FOR MONITORING OR PREDICTING WHETHER A PATIENT SUFFERING FROM OBESITY IS RESPONDING OR WILL RESPOND TO A VERY-LOW-CALORIE KETOGENIC DIET (VLCKD)

Patent number:

EP4092137A1

No items found.

The present invention refers to an in vitro method for screening and/or selecting genes whose methylation status indicates whether a patient suffering from obesity is responding or will respond to a treatment with VLCKD. Moreover, the present invention refers to an in vitro method for monitoring or predicting whether a patient suffering from obesity is responding or will respond to VLCKD.

Countries:

Spain

Regions:

Galicia

Castille and Leon

Centers:

INSTITUTO DE INVESTIGACIÓN SANITARIA DE SANTIAGO DE COMPOSTELA, UNIVERSIDAD DE SANTIAGO DE COMPOSTELA, SERGAS, UNIVERSIDAD DE VALLADOLID

Other entities:

Sectors:

Health

Subsectors:

TRL Level:

TRL 3 – experimental proof of concept

BRL Level:

PDF Link:

Download here

Video Link:

Watch it here

Sustainable Development Goal:

Applications

The present invention refers to a method for monitoring or predicting whether a patient suffering from obesity is responding or will respond to VLCKD, particularly for monitoring or predicting whether an improvement of metabolic parameters has occurred in a patient suffering from obesity after the induction of nutritional ketosis by means of a treatment with VLCKD.

Comments

Other related patents

Health

Use of telomerase reverse transcriptase for treatment of Dyskeratosis Congenita

Countries

Spain

Health

COMPOUNDS THAT SELECTIVELY AND EFFECTIVELY INHIBIT HAKAI-MEDIATED UBIQUITINATION, AS ANTI-CANCER DRUGS

Countries

Spain

Health

Gelled microspheres for the vehicleization and release of therapeutic agents

Countries

Spain

Get back to patents directory